OptimizeRx Corp (NAS:OPRX)
$ 10.49 -0.05 (-0.47%) Market Cap: 190.75 Mil Enterprise Value: 214.63 Mil PE Ratio: 0 PB Ratio: 1.51 GF Score: 78/100

Q3 2020 OPTIMIZERx Corp Earnings Call Transcript

Nov 09, 2020 / 09:30PM GMT
Release Date Price: $21.2 (-1.26%)
Operator

Good afternoon, and thank you for joining us today to discuss OptimizeRx Corporation's third quarter ended September 30, 2020. With us today are the company's Chief Executive Officer, William Febbo; Company President, Miriam Paramore; Chief Financial Officer, Doug Baker; and Chief Commercial Officer, Stephen Silvestro.

Following management's remarks today, we'll open the call for questions. Before we conclude the call today, I'll provide some important cautions regarding the forward-looking statements made by management during the call. I'd like to remind everyone that today's call is being recorded and will be made available by telephone replay via instructions in today's press release in the Investors section of the company's website.

Now I'd like to turn the call over to OptimizeRx's CEO, William Febbo. Please go ahead, sir.

William J. Febbo
OptimizeRx Corporation - CEO & Director

Thanks, Sarah, and good afternoon, everyone. Thanks for joining us on the call today. The team at OPRX is healthy, focused and very grateful to have as many

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot